InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 260.00
+0.10 (0.04%)
Feb 26, 2026, 1:02 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 142.12 million as of February 26, 2026. Its market cap has decreased by -45.64% in one year.
Market Cap
142.12M
Enterprise Value
270.97M
Revenue
243.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
260.00
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 142.12M, an increase of 2,117.55%. That is a compound annual growth rate of 22.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 142.12M | -19.68% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 124.25B |
| Danel (Adir Yeoshua) | 2.69B |
| Kamada | 1.58B |
| BrainsWay | 1.48B |
| Geffen Residence & Renewal | 263.98M |
| Epitomee Medical | 263.65M |
| Golden House | 160.13M |
| Matricelf | 154.21M |